Earnings ·
908 Devices raises full-year revenue guidance to $70M as Q2 sales rise 23% to $16.1M
MASS908 Devices Inc.
On August 11, 2026, 908 Devices Inc. reported preliminary financial results for the second quarter and fiscal year ended December 31, 2026. Revenue increased 23% year-over-year to $16.1 million, with recurring revenue representing 31% of total revenues. The company raised its full-year 2026 revenue guidance range to $68.0 million–$70.0 million, reflecting 21% to 25% year-over-year growth. Adjusted EBITDA loss narrowed by more than half compared to the prior year period. The filing also notes the acquisition of NIRLAB SA for $13.5 million and a subsequent $6 million ProtectIR order from an Asia-Pacific corrections agency. 908 Devices Inc. designs and manufactures handheld chemical analysis tools for health, safety, and defense applications.